Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Key performance metrics for wide market index funds in retirement include return consistency, volatility, and cost efficiency to monitor progress.
28,290 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
A broad coalition urges the Senate to take up the CLARITY Act, intensifying the fight over crypto regulation even as ...
eXp Realty will enable its agents to syndicate coming soon listings to multiple portals through Zenlist, broadening e...
SpaceX is aiming for a trillion-dollar-scale future by combining AI, orbital data, and lunar infrastructure. This art...
Planet Labs delivered its first full year of profitability, with a ballooning backlog and AI partnerships driving a r...
Semiconductor ETFs are leading the charge on U.S. exchanges, pushing chip-focused funds onto the most-traded lists. T...
IonQ is set to release Q1 2026 results after the bell, with investors weighing growth across five acquisitions, a Sky...
Automation momentum is accelerating, with industry observers warning that robots will replace 700,000 jobs in key sec...
Zcash jumped about 40% in a single session, signaling a renewed push for privacy-focused assets as institutions eye h...
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Toll Brothers posted a strong first quarter, underscoring resilience in the luxury segment through disciplined execut...
Bank of America raises Coherent's price target to $400 on a larger AI data center market forecast, keeping a Neutral ...